Drug class in one race
ROS1/NTRK drugs for Non-Small Cell Lung Cancer
3 tracked ROS1/NTRK drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the ROS1/NTRK page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
2 approved / phase 41 Phase 1/2